FARMARUBICIN 50MG/25ML VIAL 2 mg/ml Solution for injection Vial
FARMARUBICIN 50MG/25ML VIAL - Epirubicin Solution for Injection
Discover comprehensive information on FARMARUBICIN 50MG/25ML VIAL, drawing insights from pharmaceutical knowledge and leading e-commerce platforms like , , and .
Product Overview
FARMARUBICIN 50MG/25ML VIAL is a critical medication used in the comprehensive treatment of various cancers.
It contains Epirubicin Hydrochloride, an anthracycline cytotoxic agent that functions by interfering with the genetic material (DNA and RNA) of cancer cells, thereby inhibiting their growth and proliferation.
This sterile solution is specifically formulated for intravenous administration by healthcare professionals, ensuring targeted delivery and optimal therapeutic effect in oncology settings.
Benefits of Use
- Effectively treats a broad spectrum of solid tumors, including breast cancer, gastric cancer, ovarian cancer, lung cancer, and lymphomas.
- An integral part of established multi-drug chemotherapy regimens, enhancing overall treatment efficacy.
- Administered under strict medical supervision, ensuring precise dosing and management of potential side effects.
How to Use
- FARMARUBICIN 50MG/25ML VIAL must be administered only by qualified healthcare professionals experienced in the use of cytotoxic agents.
- The solution is intended for intravenous infusion; it should not be given intramuscularly or subcutaneously.
- Dosage and administration schedule are highly individualized, based on the specific type and stage of cancer, the patient's overall health, and response to treatment.
- Healthcare providers will dilute the concentrate for injection in an appropriate intravenous solution prior to administration.
- Careful monitoring of the patient's cardiac function, blood counts, and liver and renal function is crucial throughout the treatment period.
Caution & Warnings
- FARMARUBICIN is a potent cytotoxic drug and should only be handled and administered by personnel trained in the safe handling of antineoplastic agents.
- Patients receiving FARMARUBICIN are at risk of severe myelosuppression, which can lead to life-threatening infections and hemorrhage; regular blood counts are mandatory.
- Cardiotoxicity, including congestive heart failure, can occur; careful monitoring of cardiac function, especially with cumulative doses, is essential.
- Extravasation (leakage of the drug outside the vein) can cause severe local tissue damage and necrosis; immediate action must be taken if extravasation occurs.
- Common side effects include nausea, vomiting, alopecia (hair loss), mucositis, and fatigue.
- FARMARUBICIN is contraindicated in patients with severe myocardial insufficiency, recent myocardial infarction, severe hepatic impairment, or active systemic infections.
- Patients should be advised about potential risks to fertility and should use effective contraception during treatment and for a period thereafter.
- Not recommended for use during pregnancy or breastfeeding due to potential harm to the fetus or infant.
Ingredients
Active Ingredient: Epirubicin Hydrochloride 50 mg (equivalent to 2 mg/ml).
Excipients: Sodium Chloride, Water for Injection.
Product Details
Form: Solution for injection.
Route of Administration: Intravenous.
Strength: 50 mg per 25 ml vial (2 mg/ml).
Packaging: Single-use glass vial.
Storage Conditions: Store in a refrigerator (2°C - 8°C). Protect from light. Do not freeze.
| Gtin | 2-5381-19 |
|---|---|
| Recommended Sale Price | 166.05 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| Ingredient Name | EPIRUBICIN HYDROCHLORIDE |
| SFDA Reg. No | 2-5381-19 |
| IBC | 2-5381-19 |
| Drug Type | Prescription |
| Scientific Name | Epirubicin Hydrochloride |
| Strength | 50mg |
| Strength Unit | mg |
| Form | Solution for injection |
| Admin Route | Intravenous |
| Size | 25 |
| Size Unit | ml |
| Package Types | Vial |
| Package Size | 1 Vial |
| Storage conditions | Store in a refrigerator (2°C - 8°C). Protect from light. Do not freeze. |
| Refrigerator Storage | Yes |
